— · biotech · fertility · healthcare
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series B · Jun 2026 · $93M
RA Capital Management lead, BVF Partners lead, GV, Invus, Lumira Ventures
Reported by Ventureburn · SEC filing: $56M sold under the offering
Missing a round, or an investor who was in one? Tell us.